{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:10:14Z","timestamp":1777378214769,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T00:00:00Z","timestamp":1399334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s10552-014-0392-4","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T04:49:09Z","timestamp":1399265349000},"page":"915-922","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program"],"prefix":"10.1007","volume":"25","author":[{"given":"Birgitte","family":"Baldur-Felskov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Dehlendorff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jette","family":"Junge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Munk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne K.","family":"Kjaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,6]]},"reference":[{"key":"392_CR1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12\u201319","journal-title":"J Pathol"},{"key":"392_CR2","first-page":"S2","volume":"106","author":"BA Weaver","year":"2006","unstructured":"Weaver BA (2006) Epidemiology and natural history of genital human papillomavirus infection. J Am Osteopath Assoc 106:S2\u2013S8","journal-title":"J Am Osteopath Assoc"},{"issue":"Suppl 5","key":"392_CR3","doi-asserted-by":"crossref","first-page":"F24","DOI":"10.1016\/j.vaccine.2012.05.089","volume":"30","author":"AB Moscicki","year":"2012","unstructured":"Moscicki AB, Schiffman M, Burchell A et al (2012) Updating the natural history of human papillomavirus and anogenital cancers. Vaccine 30(Suppl 5):F24\u2013F33","journal-title":"Vaccine"},{"key":"392_CR4","unstructured":"European Medicines Agency (2010) European public assessment report for Gardasil. http:\/\/www.emea.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000703\/human_med_000805.jsp . Accessed Sept 2013"},{"key":"392_CR5","unstructured":"European Medicines Agency (2011) European public assessment report for Cervarix. http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000721\/human_med_000694.jsp&mid=WC0b01ac058001d125&murl=menus\/medicines\/medicines.jsp . Accessed Sept 2013"},{"key":"392_CR6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.vaccine.2011.11.097","volume":"30","author":"BB Sander","year":"2012","unstructured":"Sander BB, Rebolj M, Valentiner-Branth P, Lynge E (2012) Introduction of human papillomavirus vaccination in Nordic countries. Vaccine 30:1425\u20131433","journal-title":"Vaccine"},{"key":"392_CR7","unstructured":"Statens Serum Institut (2013) EPI-NYT: HPV-vaccination - tilslutning 2012. http:\/\/www.ssi.dk\/Aktuelt\/Nyhedsbreve\/EPI-NYT\/2013\/Uge%2020%20-%202013.aspx? . Accessed Sept 2013"},{"key":"392_CR8","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2165\/10898580-000000000-00000","volume":"70","author":"SM Garland","year":"2010","unstructured":"Garland SM, Smith JS (2010) Human papillomavirus vaccines: current status and future prospects. Drugs 70:1079\u20131098","journal-title":"Drugs"},{"key":"392_CR9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","volume":"121","author":"JS Smith","year":"2007","unstructured":"Smith JS, Lindsay L, Hoots B et al (2007) Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121:621\u2013632","journal-title":"Int J Cancer"},{"key":"392_CR10","author":"SK Kjaer","year":"2013","unstructured":"Kjaer SK, Munk C, Junge J, Iftner T (2013) Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS\/LSIL, HSIL, or cervical cancer: what is the potential for prevention? Cancer Causes Control. doi: 10.1007\/s10552-013-0320-z","journal-title":"Cancer Causes Control"},{"key":"392_CR11","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ygyno.2010.01.024","volume":"117","author":"M Stanley","year":"2010","unstructured":"Stanley M (2010) Pathology and epidemiology of HPV infection in females. Gynecol Oncol 117:S5\u2013S10","journal-title":"Gynecol Oncol"},{"issue":"Suppl 5","key":"392_CR12","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1016\/j.vaccine.2012.04.108","volume":"30","author":"JT Schiller","year":"2012","unstructured":"Schiller JT, Castellsague X, Garland SM (2012) A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine 30(Suppl 5):F123\u2013F138","journal-title":"Vaccine"},{"key":"392_CR13","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S (2007) Human papillomavirus and cervical cancer. Lancet 370:890\u2013907","journal-title":"Lancet"},{"key":"392_CR14","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1158\/1055-9965.EPI-13-0272","volume":"22","author":"LM Niccolai","year":"2013","unstructured":"Niccolai LM, Julian PJ, Meek JI, McBride V, Hadler JL, Sosa LE (2013) Declining rates of high-grade cervical lesions in young women in Connecticut, 2008\u20132011. Cancer Epidemiol Biomarkers Prev 22:1446\u20131450","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"392_CR15","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/S0140-6736(11)60551-5","volume":"377","author":"JM Brotherton","year":"2011","unstructured":"Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM (2011) Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 377:2085\u20132092","journal-title":"Lancet"},{"key":"392_CR16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1741-7015-11-227","volume":"11","author":"DM Gertig","year":"2013","unstructured":"Gertig DM, Brotherton JM, Budd AC, Drennan K, Chappell G, Saville AM (2013) Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study. BMC Med 11:227. doi: 10.1186\/1741-7015-11-227","journal-title":"BMC Med"},{"key":"392_CR17","unstructured":"The Danish Pathology Data Bank (2011). http:\/\/www.patobank.dk\/ . Accessed Sept 2013"},{"key":"392_CR18","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3242-6","volume-title":"Generalized linear models","author":"P McCullagh","year":"1989","unstructured":"McCullagh P, Nelder JA (1989) Generalized linear models. Chapman and Hall, London ISBN-10: 0412317605"},{"key":"392_CR19","unstructured":"R Development Core Team (2012) R: a language and environment for statistical computing. Auckland: R Foundation for Statistical Computing. Vienna, Austria. ISBN 3-900051-07-0. http:\/\/www.R-project.org . Accessed Oct 2013"},{"key":"392_CR20","unstructured":"Harrell FE Jr (2013) rms: Regression modeling strategies. R package version 3.6-3. http:\/\/cran.r-project.org\/web\/packages\/rms\/index.html . Accessed Oct 2013"},{"key":"392_CR21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/infdis\/jit192","volume":"208","author":"LE Markowitz","year":"2013","unstructured":"Markowitz LE, Hariri S, Lin C et al (2013) Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis 208:385\u2013393","journal-title":"J Infect Dis"},{"key":"392_CR22","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1016\/j.vaccine.2012.06.057","volume":"30","author":"T Cummings","year":"2012","unstructured":"Cummings T, Zimet GD, Brown D et al (2012) Reduction of HPV infections through vaccination among at-risk urban adolescents. Vaccine 30:5496\u20135499","journal-title":"Vaccine"},{"key":"392_CR23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/sextrans-2011-050234","volume":"87","author":"TR Read","year":"2011","unstructured":"Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK (2011) The near disappearance of genital warts in young women 4\u00a0years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect 87:544\u2013547","journal-title":"Sex Transm Infect"},{"key":"392_CR24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2105\/AJPH.2011.300465","volume":"102","author":"HM Bauer","year":"2012","unstructured":"Bauer HM, Wright G, Chow J (2012) Evidence of human papillomavirus vaccine effectiveness in reducing genital warts: an analysis of California public family planning administrative claims data, 2007\u20132010. Am J Public Health 102:833\u2013835","journal-title":"Am J Public Health"},{"key":"392_CR25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/OLQ.0b013e31827bd66b","volume":"40","author":"L Baandrup","year":"2013","unstructured":"Baandrup L, Blomberg M, Dehlendorff C, Sand C, Andersen KK, Kjaer SK (2013) Significant decrease in the incidence of genital warts in young danish women after implementation of a national human papillomavirus vaccination program. Sex Transm Dis 40:130\u2013135","journal-title":"Sex Transm Dis"},{"key":"392_CR26","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/infdis\/jis405","volume":"206","author":"A Leval","year":"2012","unstructured":"Leval A, Herweijer E, Arnheim-Dahlstrom L et al (2012) Incidence of genital warts in Sweden before and after quadrivalent human papillomavirus vaccine availability. J Infect Dis 206:860\u2013866","journal-title":"J Infect Dis"},{"key":"392_CR27","doi-asserted-by":"crossref","first-page":"f2032","DOI":"10.1136\/bmj.f2032","volume":"346","author":"H Ali","year":"2013","unstructured":"Ali H, Donovan B, Wand H et al (2013) Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 346:f2032","journal-title":"BMJ"},{"key":"392_CR28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/cid\/cit436","volume":"57","author":"M Blomberg","year":"2013","unstructured":"Blomberg M, Dehlendorff C, Munk C, Kjaer SK (2013) Strongly decreased risk of genital warts after vaccination against human papillomavirus: nationwide follow-up of vaccinated and unvaccinated girls in Denmark. Clin Infect Dis 57:929\u2013934","journal-title":"Clin Infect Dis"},{"key":"392_CR29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/jnci\/djt032","volume":"105","author":"A Leval","year":"2013","unstructured":"Leval A, Herweijer E, Ploner A et al (2013) Quadrivalent human papillomavirus vaccine effectiveness: a Swedish national cohort study. J Natl Cancer Inst 105:469\u2013474","journal-title":"J Natl Cancer Inst"},{"key":"392_CR30","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/infdis\/jis590","volume":"206","author":"SN Tabrizi","year":"2012","unstructured":"Tabrizi SN, Brotherton JM, Kaldor JM et al (2012) Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis 206:1645\u20131651","journal-title":"J Infect Dis"},{"key":"392_CR31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vaccine.2012.10.092","volume":"31","author":"SE Powell","year":"2012","unstructured":"Powell SE, Hariri S, Steinau M et al (2012) Impact of human papillomavirus (HPV) vaccination on HPV 16\/18-related prevalence in precancerous cervical lesions. Vaccine 31:109\u2013113","journal-title":"Vaccine"},{"key":"392_CR32","unstructured":"Statens Serum Institut (2013) Indberetning og patient registrering: Patologi. http:\/\/www.ssi.dk\/Sundhedsdataogit\/Indberetning%20og%20patientregistrering\/SEI\/Patologi.aspx . Accessed Nov 2013"},{"key":"392_CR33","unstructured":"Danske Regioner (2012) \u00d8konomisk vejledning 2008, 2010, 2011 and 2012. http:\/\/www.regioner.dk\/\u00f8konomi\/\u00f8konomisk+vejledning\/baggrundsmappe2007og2008\/regionernes+bidrag+til+patobanken+i+2008. Accessed Nov 2013"},{"key":"392_CR34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ypmed.2012.01.012","volume":"54","author":"PA Dugue","year":"2012","unstructured":"Dugue PA, Lynge E, Bjerregaard B, Rebolj M (2012) Non-participation in screening: the case of cervical cancer in Denmark. Prev Med 54:266\u2013269","journal-title":"Prev Med"},{"key":"392_CR35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","volume":"111","author":"M Arbyn","year":"2008","unstructured":"Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J (2008) Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol 111:167\u2013177","journal-title":"Obstet Gynecol"},{"key":"392_CR36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/CEJ.0b013e328359cbe0","volume":"22","author":"SS Barken","year":"2013","unstructured":"Barken SS, Rebolj M, Lynge E, Junge J, Rygaard C (2013) Outcomes in cervical screening using various cytology technologies: what\u2019s age got to do with it? Eur J Cancer Prev 22:367\u2013373","journal-title":"Eur J Cancer Prev"},{"key":"392_CR37","author":"J Rask","year":"2013","unstructured":"Rask J, Lynge E, Franzmann M et al (2013) Impact of technology on cytology outcome in cervical cancer screening of young and older women. Int J Cancer. doi: 10.1002\/ijc.28532","journal-title":"Int J Cancer"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-014-0392-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-014-0392-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-014-0392-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T23:21:33Z","timestamp":1565392893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-014-0392-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,6]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["392"],"URL":"https:\/\/doi.org\/10.1007\/s10552-014-0392-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718377293.793532227","asserted-by":"object"}]},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,6]]}}}